IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

December 30, 2025

Conditions
Non-Alcoholic Steatohepatitis (NASH)
Interventions
DRUG

Pemvidutide

Administered by subcutaneous injection

DRUG

Placebo

Administered by subcutaneous injection

Trial Locations (40)

2050

Royal Prince Alfred Hospital, Camperdown

2170

Liverpool Hospital, Liverpool

3065

St. Vincent's Hospital Melbourne, Fitzroy

3084

Austin Health, Heidelberg

3128

Box Hill Hospital, Box Hill

3168

Monash Hospital, Clayton

4102

Princess Alexandra Hospital/ Translational Research Institute, Woolloongabba

5042

Flinders Medical Centre, Bedford Park

6009

Sir Charles Gairdner Hospital, Nedlands

6150

Fiona Stanley Hospital, Murdoch

30006

Altimmune Clinical Study Site, Marietta

30720

Altimmune Clinical Study Site, Dalton

32123

Altimmune Clinical Study Site, Port Orange

33014

Altimmune Clinical Study Site, Miami Lakes

33018

Altimmune Clinical Study Site, Hialeah Gardens

33019

Altimmune Clinical Study Site, North Hollywood

33401

Altimmune Clinical Study Site, West Palm Beach

33912

Altimmune Clinical Study Site, Fort Myers

34201

Altimmune Clinical Study Site, Bradenton

34240

Altimmune Clinical Study Site, Sarasota

37040

Altimmune Clinical Study Site, Clarksville

38138

Altimmune Clinical Study Site, Germantown

71101

Altimmune Clinical Study Site, Shreveport

73301

Altimmune Clinical Study Site, Austin

77036

Altimmune Clinical Study Site, Houston

77401

Altimmune Clinical Study Site, Bellaire

78201

Altimmune Clinical Study Site, San Antonio

78204

Altimmune Clinical Study Site, San Antonio

78539

Altimmune Clinical Study Site, Edinburg

78540

Altimmune Clinical Study Site, Edinburg

78602

Altimmune Clinical Study Site, Bastrop

78626

Altimmune Clinical Study Site, Georgetown

80110

Altimmune Clinical Study Site, Englewood

84081

Altimmune Clinical Study Site, West Jordan

85224

Altimmune Clinical Study Site, Chandler

85345

Altimmune Clinical Study Site, Peoria

85701

Altimmune Clinical Study Site, Tucson

85704

Altimmune Clinial Study Site, Tucson

91402

Altimmune Clinical Study Site, Panorama City

00901

Altimmune Clinical Study Site, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Altimmune, Inc.

INDUSTRY

NCT05989711 - IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter